Related by context. All words. (Click for frequent words.) 73 psoriasis rheumatoid arthritis 70 fibrotic diseases 70 cognitive impairment associated 70 neuropathic pain spasticity 70 familial amyloidotic polyneuropathy FAP 70 thrombotic disorders 69 kidney urologic 69 fibrosis oncology 69 including thyroiditis RA 69 tiapamil 69 acetonide FA 69 ELADUR ™ 69 polyneuropathy HIV DSP 69 infectious diseases autoimmune diseases 69 immunologic diseases 69 constipation OIC 68 neuropathic pain metabolic diseases 68 ALN PCS 68 Multiple Sclerosis MS Adrenomyeloneuropathy 68 CCR9 antagonist 68 gastrointestinal mucositis 68 CYT# potent vascular disrupting 68 antiangiogenesis therapies 68 dermatological disorders 68 personalized cellular immunotherapy 68 skeletal muscle weakness 68 inflammatory autoimmune diseases 68 delivers fluocinolone acetonide FA 68 rheumatoid arthritis multiple sclerosis 68 multiple sclerosis rheumatoid arthritis 68 acne impetigo 68 macular degeneration diabetic retinopathy 68 sodium thiosulfate STS 68 identify protein biomarkers 68 hypertension osteoarthritis 68 CNS disorders 67 Ception Therapeutics 67 autoimmune uveitis 67 vitreoretinal disorders 67 systemic lupus erythematosus psoriasis 67 ophthalmic diseases 67 Disease IBD 67 liver cancers TTR 67 neovascular diseases 67 novel therapeutic antibodies 67 Ph.D. Targacept 67 lupus multiple sclerosis 67 Combivir Kivexa 67 myeloproliferative disorders 67 BioMarin develops 67 infectious diseases autoimmune 67 Zemiva TM 67 developing Bicifadine serotonin 67 epilepsy multiple sclerosis 67 novel immunotherapies 67 TRIOLEX HE# APOPTONE HE# 67 expanded autologous cellular 67 psoriasis psoriatic arthritis 67 Serostim ® 67 romazarit 67 POSIDUR TM ELADUR TM 67 vaccines oncolytic virus 67 novel VDA molecule 67 gastrointestinal disorders ATI 67 TTR amyloidosis 67 NASH Huntington 67 diarrhea predominant irritable 67 TRAIL receptor antibodies 67 commercializes innovative biopharmaceuticals 67 relapsed leukemia 66 syndrome overactive bladder 66 LymphoStat B belimumab 66 FOLOTYN ® 66 Frozen Shoulder syndrome Adhesive 66 atopic dermatitis neonatal 66 toenail onychomycosis 66 Solazed TM 66 post herpetic neuralgia PHN 66 Pharma Merck Serono 66 hereditary emphysema 66 autoimmune indications 66 dihydrochloride Tablets 66 rheumatoid arthritis Crohn disease 66 vascular occlusive diseases 66 THR beta agonist 66 non alcoholic steatohepatitis 66 sirtuin inhibitor program 66 proliferative diseases 66 Initiates Enrollment 66 Friedreich Ataxia FRDA 66 oncolytic virus therapies 66 commercialize Aganocides 66 Inc. Nasdaq ALNY 66 systemic autoimmune 66 liver cancers hypercholesterolemia 66 Ceflatonin R 66 commercialize deforolimus 66 Frozen Shoulder Syndrome 66 prokinetic agent 66 TRANSDUR ™ 66 pralatrexate injection folate analogue 66 immunotherapeutic approaches 66 microRNA therapeutics 66 cardiovascular metabolic 66 target Galectin receptors 66 constipation predominant irritable bowel 66 gastro intestinal inflammation 66 molecular imaging radiopharmaceutical 66 commercializing anti infective 66 Initiates Clinical Trial 66 refractory gout 66 neuro inflammatory 66 GI motility disorders 66 CD# CEA 66 cardio renal 66 systemic juvenile idiopathic 66 idiopathic thrombocytopenic purpura ITP 66 ACV1 66 rheumatoid arthritis inflammatory bowel 66 CTAP# Capsules 66 multiple sclerosis inflammatory bowel 66 formerly LymphoStat B 66 BCG refractory carcinoma 66 transthyretin TTR mediated amyloidosis 65 Aviptadil 65 MKC# MT 65 Provectus Pharmaceuticals specializes 65 investigational monoclonal antibody 65 JAK2 inhibitor 65 thetreatment 65 commercializing therapeutic 65 cachexia anti infectives 65 sapropterin dihydrochloride Tablets 65 commercialize microRNA therapeutics 65 DURECT proprietary 65 asthma COPD Chronic 65 epilepsy Parkinson disease 65 PNP inhibitor 65 MyVax ® 65 Acute Exacerbations 65 TRANSDUR ® 65 DNA methyltransferase inhibitors 65 metastatic bone 65 osteolytic bone disease 65 gastroenterology neurology 65 myocardial infarction ventricular fibrillation 65 cardio metabolic diseases 65 migraines neurorehabilitation 65 Oracea TM 65 inflammation autoimmune diseases 65 essential thrombocythemia ET 65 transthyretin mediated amyloidosis ATTR 65 fibrotic disorders 65 rheumatoid arthritis psoriasis 65 phenylketonuria PKU developed 65 arthritis PsA 65 immuno inflammatory 65 p# inhibitor 65 ALN TTR 65 Sudhir Agrawal D.Phil 65 GERD migraine headaches 65 Completes Patient Enrollment 65 Personalized Immunotherapy 65 Systemic lupus erythematosus SLE 65 dyslipidemia hypertension diabetes 65 CTAP# 65 including eniluracil ADH 65 Nasdaq MNKD focused 65 neuromuscular spasm 65 2 inhibitor CYT# 65 novel antibody therapeutics 65 targeted radiotherapeutic 65 rheumatoid arthritis thrombocytopenia 65 NovaBay Aganocide compounds 65 Panzem R 65 novel antiviral therapeutics 64 SinuNase ™ 64 targeting Inflammatory Bowel 64 Ostarine ™ 64 erythematosus 64 hematological diseases 64 PORxin TM platforms 64 gastrointestinal disorders characterized 64 Meets Primary Endpoint 64 Vitrasert ® 64 Alvine Pharmaceuticals 64 orally inhaled migraine 64 Genaera Corporation 64 Alzheimer disease cognitive impairment 64 NuMimetic TM 64 Therapies SRT 64 lintuzumab SGN 64 modified glutathione analog 64 mediated amyloidosis ATTR hypercholesterolemia 64 Prochymal TM 64 alfimeprase direct 64 myelofibrosis polycythemia vera 64 AMEX KAL 64 either acutely decompensated 64 equine osteoarthritis 64 Crohn disease rheumatoid arthritis 64 Fibromyalgia Syndrome FMS 64 hyperphenylalaninemia HPA due 64 rasagiline tablets 64 treat gastrointestinal disorders 64 IAP inhibitor 64 selective androgen receptor modulators 64 mGluR2 positive 64 commercializing novel biotherapeutics 64 oncology metabolic disorders 64 opioid tolerant adult 64 catheter occlusion 64 human antibody therapeutics 64 inflammation metabolic disorders 64 allosteric modulator PAM 64 Delta opioid receptor 64 chronic renal disease 64 R Saizen R 64 diarrhea vomiting rash 64 Cannabinor 64 neurology immunology 64 Vitrasert R 64 acyclovir Lauriad R 64 primary dysmenorrhea 64 aptamer therapeutics 64 TKB# 64 oral prodrug 64 Ribavirin causes 64 MTP inhibitor 64 psoriasis inflammatory bowel 64 MELAS 64 Aurexis R 64 Selzentry Celsentri 64 postherpetic neuralgia PHN painful 64 StromaCel Inc. 64 renal failure interstitial lung 64 Kuvan R 64 ALN HPN 64 myeloproliferative neoplasms 64 opioid induced constipation OIC 64 sarcoma melanoma 64 Asthma COPD 64 neuroinflammatory diseases 64 Nasdaq HALO biopharmaceutical 64 PDE# inhibitors 64 Begins Dosing 64 Crofelemer budesonide foam 64 Acute Attacks 64 Tezampanel 64 Obstructive Pulmonary Disease 64 rheumatoid arthritis psoriatic arthritis 64 Initiates Phase II 64 injury ischemic spastic 64 gastrointestinal GI disorders 64 occlusion PAO 64 include PLX IBD 64 rheumatoid arthritis RA psoriatic 64 postoperative ileus POI 64 receiving opioid analgesics 64 MCSP respectively 64 oral transdermal 64 ALTROPANE R 64 coagulation disorders 64 severe malignant osteopetrosis 64 diabetic peripheral neuropathic DPN 64 metaglidasen 64 CB2 selective receptor agonist 64 Archemix Corp. 64 Receives Orphan Drug Designation 64 epilepsy neuropathic pain 64 osteoarthritis rheumatoid arthritis 64 receiving chemoradiation therapy 64 Syncria R 64 OMNARIS HFA 64 diabetic neuropathic pain 64 neurology autoimmune diseases 64 Entereg R 64 TELINTRA 64 Alessandro Riva 63 neurotology neuropsychology headaches 63 Factor VIIa 63 ocular diseases 63 Boehringer Ingelheim MedImmune 63 opioid induced bowel dysfunction 63 vaginal candidiasis 63 class mGluR5 inhibitor 63 Amgen Neulasta R 63 pediatric Crohn disease 63 constipation IBS C 63 inflammatory autoimmune 63 hepatitis C viral infection 63 vapreotide acetate 63 diabetic retinopathy hyphema glaucoma 63 SinuNase TM 63 adenosine A2A 63 opioid induced constipation 63 psoriasis Crohn disease 63 multiple sclerosis psoriasis 63 arterial thrombosis 63 lexidronam injection 63 Insegia 63 Acute Renal Failure 63 novel RNAi therapeutics 63 RNAi therapeutic targeting 63 Nasdaq OMER biopharmaceutical 63 alpha1 antitrypsin deficiency 63 Safinamide 63 platform HDL Mimetic 63 delta gamma agonist 63 Multiple Sclerosis Rheumatoid Arthritis 63 diseases fat malabsorption 63 UCB www.ucb group.com 63 XL# anticancer compounds 63 immunodeficiency disorders 63 JAK2 Inhibitor 63 LymphoStat B TM 63 IV Busulfex 63 targeted immunotherapies 63 markets Gelclair R 63 oncology virology 63 BENLYSTA TM 63 OTCQB CTIX 63 neuro inflammatory disorders 63 endocrine diseases 63 TM Aganocide 63 GVAX ® 63 Viprovex TM 63 Romidepsin 63 diseases bone metastasis 63 NYSE Amex AEN 63 carcinoid syndrome 63 asthma allergic rhinitis 63 oral Janus kinase 63 Morria Biopharmaceuticals Plc 63 sapropterin dihydrochloride 63 Anthony Giovinazzo 63 VentiRx Pharmaceuticals 63 musculoskeletal diseases 63 Brussels THR 63 NeurAxon Inc. 63 REMOXY ® 63 P#X# antagonist 63 Inflammatory Diseases 63 Kleanthis G. Xanthopoulos Ph.D. 63 BENLYSTA ® 63 novel anti infective 63 JAK1 63 Uli Hacksell Ph.D. 63 candidates Azedra TM 63 Zenvia ™ 63 systemic fungal infections 63 Ridaforolimus 63 tizanidine hydrochloride short 63 Liprotamase 63 Nasdaq IDIX biopharmaceutical 63 Kuvan TM sapropterin 63 post herpetic 63 cosmetic cosmeceutical products 63 collagen vascular 63 painful diabetic neuropathy 63 leukemia AML 63 ankylosing spondylitis psoriatic arthritis 63 dasatinib Sprycel ® 63 orally administered pharmacological chaperones 63 alpha1 antitrypsin AAT deficiency 63 Fx #A 63 respiratory gastrointestinal 63 GATTEX TM 63 forodesine 63 glucokinase activator 63 multiple sclerosis lupus 63 diabetic gastroparesis 63 Smac mimetics 63 Crohns disease 63 AFREZZA TM 63 orally administered inhibitor 63 product platforms AZX# 63 ZFP Therapeutics 63 diabetes irritable bowel 63 Amigal TM 63 Pyridorin 63 PDE4 modulators 63 overactive bladder syndrome 63 investigating Serdaxin 63 anti infective treatments 63 blood coagulation disorders 63 pharmacological chaperone compounds 63 Prodarsan R 63 terlipressin 63 thiazolides 63 Dementia Related Psychosis 63 commercializing aptamer therapeutics 63 investigational compounds 63 venomics 63 AAG geldanamycin analog 63 HIV distal sensory 63 Solazed ™ 63 Dosa suffers 63 purinergic receptors P#X# 63 TNF Tumor Necrosis Factor 63 renin inhibition promising 63 IAP inhibitors 63 induced macular edema 63 EVIZON TM squalamine lactate 63 Xcytrin R 63 including acne photodamage 63 HepDirect R 63 severe degenerative ischemic 63 rheumatoid arthritis gout 63 neuropsychiatric diseases 63 Acute Bacterial Sinusitis ABS 63 acute peripheral arterial 63 delay bone metastases 63 MKC# MKC# PP 63 Arno Therapeutics 63 neurology cardiovascular GIT 63 Archexin 63 cardiometabolic diseases 63 Familial Adenomatous Polyposis FAP 62 progressive neurodegenerative 62 aerosolized AAT 62 FDA APPROVES 62 Cerimon 62 overactive bladder AA# 62 pseudobulbar affect PBA 62 Sezary syndrome 62 Adenosine Therapeutics 62 Leber Congenital Amaurosis LCA 62 Nasdaq PGNX 62 neurovascular diseases 62 chronic eosinophilic leukemia 62 Hepatitis B Hepatitis C 62 nephropathic cystinosis 62 AAT Deficiency 62 refractory chronic lymphocytic 62 GlycoPEGylated hemostasis compounds 62 candidates Azedra 62 Stanate R 62 R sorafenib tablets 62 GEM OS2 62 rusalatide acetate 62 hypereosinophilic syndrome 62 degenerative disorders 62 chronic thromboembolic pulmonary 62 protein tyrosine phosphatase 1B 62 small molecule therapeutics 62 treat dysmenorrhea 62 phenylalanine ammonia lyase 62 neuro degenerative diseases 62 degeneration gastrointestinal disorders 62 pharmacological chaperone 62 CysDisplay R 62 antibody MAb 62 rheumatoid arthritis osteoarthritis ankylosing 62 immunological diseases 62 Simulect 62 sorafenib tablets 62 ophthalmology oncology 62 AEG# 62 cMET 62 2 methoxyestradiol 62 Zemiva TM Trofex TM 62 cause cardiac channelopathies 62 macular edema secondary 62 Xyfid TM 62 NASDAQ LGND 62 5 HT4 62 inflammatory disorders 62 GW# [003] 62 rheumatoid arthritis juvenile idiopathic 62 erythematosus SLE 62 Namenda ® 62 Selective Electrochemical Tumor Ablation 62 congenital ichthyosis 62 COPD asthma 62 Lenocta TM 62 leukotriene pathway 62 developing Surfactant Replacement 62 receptor modulators 62 SYN# 62 investigational therapies 62 Central Retinal Vein 62 lead molecular radiotherapeutic 62 ophthalmology dermatology 62 Zingo TM 62 Daclizumab 62 steroid refractory ulcerative 62 Veronate R 62 vidofludimus 62 Modrenal R 62 vascular disorders 62 Epiphany Biosciences 62 multiple sclerosis fibromyalgia 62 pharmacogenomic translational research 62 Investigational Treatment 62 chronic progressive neurodegenerative 62 Auxilium transmucosal film 62 autoimmune inflammatory 62 treat chronic sinusitis 62 NS5b 62 Cx# [002] 62 MEDAREX 62 products MKC# PP 62 Novel Oral 62 dermatological diseases 62 Onalta TM 62 cystic fibrosis inflammation autoimmune 62 markets HP Acthar 62 INxin TM 62 muscular dystrophy cystic fibrosis 62 Zorbtive TM 62 markets Testim ® 62 Excellarate TM 62 Aganocide 62 Vincent Mutel CEO 62 manufactures minimally invasive 62 Surfactant Replacement Therapies SRT 62 induced mucositis 62 neurogenic bladder 62 pruritus rash 62 protein misfolding diseases 62 investigational hepatitis C 62 Wafer polifeprosan 62 mGluR5 PAM 62 RNA antagonists 62 EnzymeRx 62 Nasdaq HALO 62 candidate XP# 62 myasthenia gravis Huntington 62 Associated Adipose Redistribution 62 oxypurinol 62 HGS ETR1 mapatumumab 62 OTCBB NVLT biopharmaceutical 62 YM AIM YMBA 62 osteoarthritic pain 62 TLR9 agonist IMO 62 rxRNA 62 CIMZIA r certolizumab pegol 62 arteriovenous malformations 62 ocular formulation 62 atypical Hemolytic Uremic Syndrome 62 Shigatoxin producing E. coli 62 cardiometabolic disorders 62 Promedior 62 hypercholesterolemia liver 62 Gastrointestinal Liner 62 RhuDex ® 62 cardiovascular metabolic diseases 62 Luveris R Ovidrel R 62 Squalamine 62 cell lymphoma CTCL 62 Lupus Nephritis 62 InfaCare Pharmaceutical Corporation 62 commercializing Loramyc ® 62 NNR Therapeutics 62 OTCBB HXBM developer 62 Files IND 62 investigational pharmacologically unique 62 miconazole Lauriad ® 62 Injury ALI 62 TNF alpha selectively neutralizing 62 Nanobody 62 OMP #R# 62 Nasdaq IDRA 62 beta 1a 62 pancreas colon 62 pipeline GlycoPEG GCSF 62 R MSCRAMM 62 peripherally acting 62 palonosetron hydrochloride Injection Dacogen 62 ionotropic glutamate receptor antagonists 62 fibrosis IPF 62 Cerimon Pharmaceuticals Inc. 62 Frozen Shoulder syndrome 62 sJIA 62 Initiates Phase III 62 INSPIRE Trial Phase III 62 selective angiogenic kinase inhibitor 62 inflammatory diseases 62 Satori Pharmaceuticals 62 retinal vein occlusion induced 62 therapeutic monoclonal antibodies 62 Inc. Nasdaq NLTX 62 renal diseases 62 Namenda Memantine HCl 62 gastrointestinal GI motility disorders 62 NASDAQ SNTA biopharmaceutical 62 M# rationally 62 samarium Sm 62 Tasimelteon 62 acquired pneumonia HAP 62 candidate deforolimus 62 Peyronie disease Frozen Shoulder 62 Monoclonal antibody 62 OTCBB INSV 62 DDP# 62 HYVISC R 61 diagnostic molecular imaging 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 www.ucb group.com 61 lupus erythematosus 61 sterile lidocaine patch 61 HPV cervical dysplasia 61 psoriatic arthritis PsA 61 mGluR2 NAM 61 selective immunoproteasome inhibitor 61 haemato oncology 61 Garo H. 61 Phase 2b Clinical Trial 61 DepoDur 61 autoimmune diseases 61 opioid bowel dysfunction 61 albiglutide currently 61 damage cirrhosis liver 61 drug ISA# 61 skeletal muscle contractility 61 Evoltra ® 61 hematologic disorders 61 inflammatory cardio metabolic 61 dextromethorphan quinidine 61 platforms GVAX 61 Adnectin 61 castrate resistant prostate cancer 61 bronchospasm dizziness headache 61 Intarcia 61 Parkinson disease Alzheimer disease 61 oral dual endothelin 61 TSX VIR 61 CIPN 61 anti botulism antibody 61 oropharyngeal candidiasis OPC 61 non personalized allogeneic 61 lipid disorders 61 Conatus Pharmaceuticals 61 PDX pralatrexate 61 sanofi aventis Bayer Schering 61 Unigene nasal calcitonin 61 humanized interleukin 6 61 GRN# 61 subsidiaries visit http:/www.apricusbio.com 61 milnacipran HCl 61 triggers apoptosis programmed 61 Neurodegenerative diseases 61 cyclophilin inhibitors 61 therapeutic monoclonal antibody 61 methylnaltrexone bromide 61 treat musculoskeletal metabolic 61 ocular disorders 61 ulcerative colitis Crohn disease 61 PEGylated Fab fragment 61 Quinamed R 61 non porcine pancreatic 61 Navelbine ® 61 levodopa induced 61 topical anti infective 61 Cethrin R 61 Generx TM 61 secondary hyperparathyroidism 61 HQK 61 telomerase therapeutic 61 OTC BB PVCT 61 Locked Nucleic Acid 61 OTCBB CVBT 61 small molecule thrombopoietin 61 interferon alpha IFN 61 debilitating complication 61 Myelodysplastic Syndrome MDS 61 hyperplasia BPH 61 myelodysplastic myeloproliferative diseases 61 BEMA Buprenorphine 61 OTCBB URGP specialty 61 NTDDS 61 isoform selective 61 Postherpetic neuralgia PHN 61 metastatic carcinoid 61 AMEX REX 61 nebulized budesonide 61 complement inhibitor eculizumab 61 syndrome gastroesophageal reflux 61 DiaKine 61 ® bortezomib 61 interferon beta 1a infertility 61 Agonist MABA program 61 Budesonide foam crofelemer 61 Pruvel TM 61 cirrhosis liver failure 61 aldehyde dehydrogenase ALDH2 deficiency 61 immune modulating drug 61 SUPPRELIN R LA 61 delayed CINV 61 Unit Dose Budesonide 61 MuGard TM 61 HCl PEPCID ® famotidine 61 Exploit collaboration 61 Commercialize Novel 61 OTCBB CHKT biotechnology 61 cutaneous T 61 Proquin XR 61 Trofex TM 61 delivery polymer matrix 61 receptor tyrosine kinase inhibitor 61 MediGene focuses 61 prescribed proton pump 61 SARMs 61 MPH AMEX 61 diabetic macular edema DME 61 MOVIPREP R 61 Afferent Pharmaceuticals 61 Regado Biosciences 61 SILENOR TM doxepin HCl 61 TÎ ² 4 61 oral salmon calcitonin 61 Panzem ® 61 MultiCell Technologies 61 Phase IIb clinical trials 61 commercializes biotherapeutics 61 BHT DNA 61 Metabasis Therapeutics Inc. 61 Neogenix 61 rheumatoid arthritis Roche PEGASYS 61 pediatric endocrinology urology orthopedics 61 Fibrin MB 61 Cutaneous T 61 Iluvien ® 61 treating cancerous tumors 61 Idera Pharmaceuticals 61 Immunotherapeutic 61 Telik logo TELINTRA 61 oral nucleoside analogue 61 Tramiprosate ALZHEMED TM 61 Phase 2b Trial 61 Pseudomonas aeruginosa infections 61 Saizen ® 61 rheumatoid arthritis psoriasis Crohn 61 ATTR PN 61 rALLy clinical trial 61 Leber Hereditary Optic Neuropathy 61 inflammatory demyelinating 61 oral ghrelin agonist 61 Albugon 61 Onalta 61 CYT# vascular disrupting 61 INS# [001] 61 AMEX RGN 61 Phenomix Corporation 61 AzaSite Xtra 61 Angiocept 61 Annamycin 61 Cerebril TM 61 OTCBB IMUC 61 dermatology therapies 61 Inc. OTCBB SPRX 61 Troxatyl 61 erlotinib Tarceva R 61 aripiprazole Abilify 61 XmAb ® 61 IL# PE#QQR 61 diarrhea fatigue asthenia 61 Pharmos pipeline 61 Janus Kinase 61 Logical Therapeutics 61 Vascular Endothelial Growth 61 pregabalin Lyrica 61 commercialize CorMedix drug 61 metastatic colorectal 61 MKC# 61 Omacetaxine 61 VYVANSE TM lisdexamfetamine 61 OTC BB PVCT http:/www.pvct.com 61 dirucotide MBP# 61 Fabry Disease 61 J. Donald deBethizy 61 EnVivo Pharmaceuticals 61 NASDAQ PPHM clinical 61 arthritis cardiovascular disease 61 Alzheimer Disease Parkinson Disease 61 Epeius Biotechnologies Corporation 61 nausea vomiting vertigo 61 PEG PAL PEGylated recombinant 61 rheumatoid arthritis lupus 61 muscarinic receptor agonist 61 Augment TM 61 ELADUR TM 61 FUSILEV ® 61 transplantation HCT 61 endocrinology gastroenterology 61 Syndax Pharmaceuticals Inc. 61 cystic fibrosis chronic pancreatitis 61 retinal degenerations 61 Pancreate 61 anti inflammatory NSAID 61 IV FENTORA R 61 pathophysiological effects 61 infection sinusitis 61 Hervé Hoppenot President 61 Rhucin ® recombinant 61 Mucositis 61 peripheral arterial occlusive disease 61 Mesoblast Limited ASX MSB 61 doxepin HCl 61 REGENERX BIOPHARMACEUTICALS INC. 61 elotuzumab 61 diabetes mellitus autoimmune disorders 61 postherpetic neuralgia PHN 61 Pegloticase 61 HCV polymerase inhibitors 61 systemic lupus erythematosus lupus 61 commercialize becocalcidiol patented 61 Nasdaq VNDA 61 TLK# 61 NASDAQ ABII 61 Vidaza ® 61 pancreatic prostate 61 CRMD pharmaceutical 61 Bucindolol 61 HuCAL PLATINUM ® CysDisplay 61 spinal stenosis degenerative disc 61 Entereg TM 61 herpetic keratitis 61 NYSE Amex PTN 61 Complicated Skin 61 REMOXY R 61 MPS VI 61 neuroscience autoimmune 61 TRIOLEX HE# 61 Rebif ® 61 Prism Pharmaceuticals 61 chemically modified tetracyclines 61 chronic neuropathic pain 61 Aryplase 61 Frankfurt XMP 61 Bronchiectasis 61 Trimesta 61 Amex KAL 60 HuCAL PLATINUM R 60 vaginally administered lidocaine 60 pouchitis 60 torsemide ER 60 KL4 Surfactant 60 apomorphine hydrochloride 60 Gel repository corticotropin injection 60 Zemiva ™ 60 photodynamic treatment 60 generation DACH Platinum 60 pharmacologic therapies 60 STELARA TM 60 PGL# 60 AVAPRO 60 autotransfusion systems 60 IMiDs 60 cutaneous lupus 60 TKM ApoB 60 Nasdaq LXRX biopharmaceutical 60 developing ostarine selective 60 NYSE PFE Exelon Rivastigmine 60 pulmonary hypertension PH 60 Fibrillex TM 60 SAR# [002] 60 novel peptides 60 Nanobody ® 60 Therapeutic Competitors Companies 60 attacks TIAs 60 HIF biology 60 dexanabinol 60 virus HCV protease inhibitor 60 NU# direct 60 Reminyl galantamine 60 hypoxia activated prodrug 60 included exfoliative dermatitis 60 deforolimus 60 unresectable tumors 60 Tectin TM 60 Duchene muscular dystrophy 60 COLAZAL R 60 debilitating autoimmune 60 PF # [002] 60 Diabetic Macular Edema DME 60 Proxinium 60 Treatment Shows Promise 60 Ecallantide 60 Avila Therapeutics 60 Cellegy Pharmaceuticals 60 DGAT1 inhibitors 60 Savella ® 60 osteoporosis osteoarthritis 60 ocular inflammatory 60 diabetic peripheral neuropathy 60 MetroGel 60 mu opioid receptor antagonist 60 neurogenic orthostatic hypotension 60 hepatitis B HBV 60 Sphingomab TM 60 Quark Biotech 60 Gastrointestinal GI 60 Reports Preclinical Data 60 relapsed multiple myeloma 60 Solzira TM 60 essential thrombocythemia 60 OTCBB PYTO 60 common neurovascular complication 60 IRX Therapeutics 60 Teikoku Pharma USA 60 HuCNS SC ® 60 subsidiaries Laboratorios Belmac Laboratorios 60 ACTIQ ® 60 gastrointestinal malignancies 60 TRO# 60 Inc. NASDAQ IDIX 60 venous stasis ulcers 60 peptide peptide mimetic 60 product Fentanyl TAIFUN 60 Creabilis Therapeutics 60 ATRA IV 60 PD2i CA Cardiac Analyzer 60 hematologic diseases 60 mGluR4 PAM 60 Janus kinase 60 Through Glycoscience R 60 Inc. AMEX YMI 60 EVIZON TM 60 oral picoplatin 60 idiopathic pulmonary fibrosis IPF 60 Phase 2a Clinical Trial 60 ankylosing spondylitis AS 60 chronic myocardial ischemia 60 POSIDUR ™ 60 multiple sclerosis Crohn disease 60 inhaled liposomal ciprofloxacin 60 Amgen Neulasta ® 60 basiliximab 60 Nasdaq NPSP 60 cytomegalovirus CMV retinitis 60 erlotinib Tarceva ® 60 malignant infectious 60 oncology infectious diseases 60 Endotis 60 XP# XP# 60 zanolimumab 60 Spiegelmer ® 60 acetylgalactosamine 6 60 candidate Zelrix 60 FOLFOX6 chemotherapy regimen 60 Campath ® 60 signal transduction inhibitors 60 ZFP Therapeutic ® 60 Diabetic Neuropathy 60 Retisert ® 60 musculoskeletal metabolic 60 glaucoma ischemia 60 severe hypercholesterolemia 60 PMX # antibiotic 60 mGluR4 60 immune idiopathic thrombocytopenic 60 colorectal bladder 60 Parkinson disease multiple sclerosis 60 Chemokine Therapeutics 60 PLX MS 60 Cetrorelix 60 gastrointestinal disorders 60 Repligen Corporation 60 G Protein Coupled 60 PEGylated anti 60 Xanafide 60 Rheumatoid Arthritis RA 60 FoldRx Pharmaceuticals Inc. 60 alpha interferons 60 AVONEX ® 60 diabetes hyperlipidemia 60 BCR ABL inhibitors 60 myeloproliferative neoplasms MPNs 60 polycythemia vera essential thrombocythemia 60 Merck OSI Pharmaceuticals 60 LHRH antagonists 60 iSONEP TM 60 agonistic human 60 candidate CRLX# 60 Fludara ® 60 Nasdaq ASTM 60 urologic disease 60 SNT MC# 60 Nanobody R 60 angiogenic responses 60 ONCONASE R 60 nosocomial pneumonia 60 vWD 60 Idiopathic pulmonary fibrosis 60 Corp. NASDAQ PSDV 60 targeting PCSK9 60 4SC AG ISIN DE# 60 Opterone R 60 Fovea Pharmaceuticals subsidiary 60 Announces Poster Presentations 60 asthma emphysema bronchitis 60 mucositis ProLindac ™ 60 sapacitabine CYC# 60 dermatologic diseases 60 dutogliptin 60 bone marrow reticulin deposition 60 Belimumab